Ardelyx reported $-14400000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Abbott USD 2.07B 415M Jun/2025
Amgen USD 2.66B 1.37B Jun/2025
Ardelyx USD -14400000 22.52M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Life Technologies USD -20310000 4.49M Jun/2025
Sanofi EUR 1.71B 851M Jun/2025
TG Therapeutics USD 34.84M 26.22M Jun/2025
United Therapeutics USD 276.9M 105.9M Jun/2025